Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Clonal Anergy | 4 | 2013 | 31 | 1.260 |
Why?
|
| Early Growth Response Protein 2 | 3 | 2017 | 17 | 1.000 |
Why?
|
| T-Lymphocytes | 6 | 2014 | 1224 | 0.780 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2012 | 112 | 0.450 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2010 | 55 | 0.440 |
Why?
|
| Diacylglycerol Kinase | 1 | 2012 | 5 | 0.430 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 123 | 0.410 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 956 | 0.370 |
Why?
|
| Smad2 Protein | 1 | 2010 | 22 | 0.370 |
Why?
|
| Smad3 Protein | 1 | 2010 | 25 | 0.370 |
Why?
|
| Insulin Resistance | 2 | 2010 | 353 | 0.360 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 125 | 0.350 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2009 | 46 | 0.340 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 324 | 0.310 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 1431 | 0.300 |
Why?
|
| Tumor Microenvironment | 4 | 2017 | 463 | 0.280 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 1976 | 0.240 |
Why?
|
| Obesity | 1 | 2009 | 971 | 0.210 |
Why?
|
| Mice, Knockout | 5 | 2014 | 2001 | 0.190 |
Why?
|
| Mice, Transgenic | 4 | 2013 | 1574 | 0.190 |
Why?
|
| CD28 Antigens | 2 | 2013 | 90 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2013 | 394 | 0.180 |
Why?
|
| Mice | 10 | 2017 | 11761 | 0.180 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2013 | 275 | 0.180 |
Why?
|
| Animals | 14 | 2017 | 27371 | 0.180 |
Why?
|
| Lymphocyte Activation | 4 | 2013 | 751 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 887 | 0.170 |
Why?
|
| Base Sequence | 2 | 2013 | 2327 | 0.160 |
Why?
|
| Phosphoproteins | 2 | 2010 | 261 | 0.150 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2017 | 17 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 6 | 2017 | 3218 | 0.140 |
Why?
|
| Signal Transduction | 5 | 2012 | 3385 | 0.140 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 131 | 0.130 |
Why?
|
| Phosphorylation | 4 | 2013 | 1132 | 0.130 |
Why?
|
| Antigens, CD | 1 | 2017 | 466 | 0.120 |
Why?
|
| Immunoblotting | 2 | 2012 | 273 | 0.120 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2014 | 20 | 0.120 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 332 | 0.120 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 111 | 0.110 |
Why?
|
| Interferon-beta | 1 | 2014 | 126 | 0.110 |
Why?
|
| Gene Targeting | 1 | 2013 | 73 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 595 | 0.110 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2012 | 27 | 0.110 |
Why?
|
| Luciferases | 1 | 2012 | 128 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 136 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 136 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 364 | 0.100 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 317 | 0.100 |
Why?
|
| Eye | 1 | 2012 | 111 | 0.100 |
Why?
|
| Intraoperative Awareness | 1 | 2011 | 2 | 0.100 |
Why?
|
| Consciousness Monitors | 1 | 2011 | 3 | 0.100 |
Why?
|
| DNA Primers | 1 | 2012 | 543 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2013 | 2884 | 0.100 |
Why?
|
| Pulmonary Alveoli | 1 | 2011 | 71 | 0.090 |
Why?
|
| Phospholipase C gamma | 1 | 2010 | 15 | 0.090 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 996 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2012 | 691 | 0.090 |
Why?
|
| Monitoring, Intraoperative | 1 | 2011 | 110 | 0.090 |
Why?
|
| Anesthetics, Inhalation | 1 | 2011 | 98 | 0.090 |
Why?
|
| Mice, 129 Strain | 1 | 2010 | 56 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 899 | 0.090 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2010 | 45 | 0.090 |
Why?
|
| Anesthesia, General | 1 | 2011 | 118 | 0.090 |
Why?
|
| Binding Sites | 1 | 2013 | 1117 | 0.090 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 221 | 0.090 |
Why?
|
| Ubiquitination | 1 | 2010 | 73 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 69 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 645 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 106 | 0.090 |
Why?
|
| Rats, Zucker | 1 | 2009 | 38 | 0.090 |
Why?
|
| Caloric Restriction | 1 | 2009 | 14 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 340 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 414 | 0.080 |
Why?
|
| Immunological Synapses | 1 | 2009 | 5 | 0.080 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2009 | 42 | 0.080 |
Why?
|
| RNA Interference | 1 | 2010 | 376 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 267 | 0.080 |
Why?
|
| Protein Binding | 1 | 2013 | 1488 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2010 | 519 | 0.080 |
Why?
|
| beta Catenin | 1 | 2010 | 266 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 313 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2010 | 794 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2009 | 274 | 0.080 |
Why?
|
| Protein Kinase C | 1 | 2009 | 268 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 3027 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2012 | 1224 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2010 | 1652 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2013 | 682 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2010 | 755 | 0.070 |
Why?
|
| Glucose | 1 | 2010 | 630 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 71 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 77 | 0.070 |
Why?
|
| Neoplasms | 2 | 2013 | 3041 | 0.070 |
Why?
|
| Gene Expression | 1 | 2010 | 1310 | 0.070 |
Why?
|
| Liver | 1 | 2009 | 1208 | 0.060 |
Why?
|
| Rats | 1 | 2009 | 4041 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 2415 | 0.050 |
Why?
|
| Proteins | 1 | 2008 | 787 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2017 | 1412 | 0.040 |
Why?
|
| Male | 3 | 2011 | 42411 | 0.040 |
Why?
|
| CHO Cells | 2 | 2010 | 187 | 0.040 |
Why?
|
| Cytokines | 2 | 2013 | 803 | 0.040 |
Why?
|
| Hepatocytes | 2 | 2010 | 119 | 0.040 |
Why?
|
| Cricetinae | 2 | 2010 | 558 | 0.040 |
Why?
|
| Humans | 6 | 2013 | 89357 | 0.040 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2017 | 30 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 1157 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2017 | 251 | 0.030 |
Why?
|
| Cell Line | 2 | 2012 | 2496 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 451 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 2014 | 98 | 0.030 |
Why?
|
| Female | 3 | 2017 | 46202 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2013 | 73 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2014 | 171 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2013 | 160 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2013 | 215 | 0.030 |
Why?
|
| Pericytes | 1 | 2012 | 13 | 0.030 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2012 | 9 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2014 | 275 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 32 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2012 | 57 | 0.030 |
Why?
|
| B7-H1 Antigen | 1 | 2014 | 274 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2013 | 342 | 0.030 |
Why?
|
| Cell Division | 1 | 2013 | 696 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 565 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 150 | 0.020 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 2010 | 12 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 695 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 382 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2010 | 75 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2010 | 44 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 389 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 126 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 739 | 0.020 |
Why?
|
| Protein Kinase C-theta | 1 | 2009 | 16 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 138 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 323 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 2558 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2010 | 430 | 0.020 |
Why?
|
| Cell Movement | 1 | 2010 | 784 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2011 | 751 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 2017 | 0.020 |
Why?
|
| Flavonoids | 1 | 2006 | 87 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 975 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 387 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1525 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2011 | 4289 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2011 | 2284 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 5499 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 19165 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 25974 | 0.010 |
Why?
|
| Adult | 1 | 2011 | 26607 | 0.010 |
Why?
|